超声造影在评估肝脏肿瘤术后疗效的作用  

Curative Effect of Contrast-enhanced Ultrasound after the Treatment of Liver Tumor

作　　者：张嫄[1] 孟繁坤[1] 高燕[1] 徐晓鸾[1] 

机构地区：[1]首都医科大学附属北京佑安医院功能检测科,北京市100069

出　　处：《中国超声医学杂志》2010年第10期925-928,共4页Chinese Journal of Ultrasound in Medicine

摘　　要：目的通过超声造影评估肝癌治疗术后靶治疗区灭活情况。方法分析42例肝脏肿瘤患者行局部治疗后的超声造影表现,与同期增强CT进行对比分析,两检查参照标准为肝动脉血管造影。结果 42例中超声造影判断未完全灭活17例,完全灭活25例,增强CT判断未完全灭活14例,完全灭活28例,超声造影判别肝脏肿瘤治疗后灭活灵敏度为82.4%,特异度为96%,符合率为90.4%。由于两者一致性检验的Kappa值=0.751>0.75,说明超声造影与增强CT的诊断一致性较好。结论超声造影对肝癌局部治疗后的评估提供了可靠的诊断依据,具有重要的临床价值。Objective To assess inactivation of the targeted treatment area after Liver cancer therapy by contrast- enhanced ultrasound. Methods Sonograph of contrast-enhanced ultrasound of 42 liver cancer patients after undergoing local treatment were analysed and compared with the enhanced CT from the same period. The reference standard for the two inspections was hepatic artery angiography. Results Among 42 cases of contrast-enhanced ultrasound,17 cases were not completely inactivated. 25 cases were completely inactivated, While according to enhanced CT, 14 cases were not completely inactivated. 28 cases were completely inactivated. The sensitivity was 82.4% after treatment of liver tumor by contrast-enhanced ultrasound. The specificity was 96%. The accuracy was 90.4%0. The Kappa value of both consistency test was 0. 751 which was greater than 0.75,indicating that the consistency was better, between contrast- enhanced ultrasound and enhanced CT diagnosis. Conclusions Contrast-enhanced ultrasound can provide a reliable basis for the diagnosis of liver cancer after local treatment with important clinical value.

关 键 词：超声造影 肝脏肿瘤 治疗疗效 

分 类 号：R445.1[医药卫生—影像医学与核医学] R735.7[医药卫生—诊断学]